Effect of Bupropion versus placebo on the management of fatigue caused by multiple sclerosis
Phase 3
- Conditions
- Multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT20120215009014N465
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
Age 18 to 65 years
Multiple sclerosis
Exclusion Criteria
Pregnancy or breastfeeding
Hepatic or renal failure
A history of convulsion or epilepsy
A history of alcohol use
A history of attempting suicide
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatigue score. Timepoint: Before the intervention and one and two months after the intervention. Method of measurement: Using the Modified Fatigue Impact Scale (MFIS).;Quality of life score. Timepoint: Before Intervention and two months after the intervention. Method of measurement: Using Multiple Sclerosis Quality of Life-54 Questionnaire (MSQOL-54).;Disability score. Timepoint: Before the intervention and one and two months after the intervention. Method of measurement: using the Expanded Disability Status Scale (EDSS).
- Secondary Outcome Measures
Name Time Method